Sleep Disturbance clinical trials

Explore recruiting sleep disturbance clinical trials.

Recruiting sleep disturbance studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sleep Disturbance trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Sleep structure in neuropathic pain patients, psychological factors, brain connectivity, and the effect of pregabalin on sleep and pain

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients with MPSIIIA.

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Randomized, Placebo-controlled, Double-blind, Phase 3 Clinical Study to Investigate the Efficacy and Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms (Hot Flashes) in Women with Stage 0 to 3 Hormone Receptor-positive Breast Cancer Who Are Receiving Adjuvant Endocrine Therapy

Hungary, Denmark, Italy, Czechia, Germany, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

(22423 NIRVANA) A randomized, parallel-group treatment, Phase 2, double-blind pilot study to investigate the efficacy and safety of elinzanetant compared with placebo for treatment of sleep disturbances associated with menopause

Germany, Austria, Belgium, Netherlands, Poland, Czechia +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients: A Pilot Double-Blind Randomized Controlled Trial.(GAMMA-SLEEP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Sleep Disturbance trials by city

Sleep Disturbance in Toronto Sleep Disturbance in Vancouver Sleep Disturbance in Montreal Sleep Disturbance in Calgary Sleep Disturbance in Edmonton Sleep Disturbance in Ottawa Sleep Disturbance in Winnipeg Sleep Disturbance in Quebec City Sleep Disturbance in Hamilton Sleep Disturbance in Kitchener Sleep Disturbance in London Sleep Disturbance in Halifax Sleep Disturbance in New York Sleep Disturbance in Los Angeles Sleep Disturbance in Chicago Sleep Disturbance in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease